NR4A1 and colorectal cancer: Recent studies have also confirmed the potential of some ginsenosides as promising compounds for treating colorectal cancer [4]; for example, the treatment of hypoxic colorectal cancer cells with ginsenoside Compound K significantly blocked Nur77-mediated carcinogenic signaling, inhibiting the cancer stem-cell-like cells characteristics and metastasis in vitro and in vivo [5].